Edgewise Therapeutics (EWTX) operating margin

There is no operating margin history on record here for Edgewise Therapeutics (EWTX). Figures as of 17 Nov 2026, 21:32 UTC, from the company's filings with the SEC and Yahoo Finance.

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Not enough data

A history of operating margin needs at least 3 fiscal years; none is on record here for Edgewise Therapeutics. Nothing is estimated to fill the gap.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of Edgewise Therapeutics and comparable companies
CompanyOperating marginFiscal year
Concentra Group Holdings Parent CON15.4%2025
Merit Medical Systems MMSI12.3%2025
LivaNova LIVN14.4%2025
Ionis Pharmaceuticals IONS-40.4%2025
Dianthus Therapeutics DNTH-8739.3%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on EWTX

Edgewise Therapeutics, figure by figure

Edgewise Therapeutics (EWTX) overview: price, valuation and scorecardAll health care companies by market value

Edgewise Therapeutics operating margin: questions and answers

How is Edgewise Therapeutics's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Edgewise Therapeutics (EWTX) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/EWTX/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.